Hugh McElderry
Clinical Cardiac Electrophysiology · Birmingham, ALNPI 1174552004
Payments from drug & device makers
What this record shows
This record is dominated by other: $539,767 of the $725,289 with a category attached, or 74.4%. Boston Scientific accounts for 80.5% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2021 at $280,969 and has fallen 78.6% since, to $60,210 in 2025. Among clinical cardiac electrophysiology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 243 payments — averaging $2984.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$584K
- Cardiva Medical, Inc.$46K
- Biosense Webster, Inc.$44K
- Medtronic$23K
- Abbott$20K
- Altathera Pharmaceuticals LLC$4K
- plus $4K from 14 others
Across 283 payments — averaging $4244.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$568K
- Cardiva Medical, Inc.$219K
- Abbott$158K
- Medical Device Business Services, Inc.$129K
- Haemonetics Corporation$53K
- Kardium Inc.$38K
- plus $35K from 1 others
What the payments were for
- Consulting fees$107,87415%
- Speaking & faculty fees$49,8757%
- Travel & lodging$19,6273%
- Food & beverage$8,1471%
- Other$539,76774%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 48 | $584,165 |
| Cardiva Medical, Inc. | 18 | $45,959 |
| Biosense Webster, Inc. | 27 | $43,905 |
| Medtronic(2 entities) | 52 | $22,678 |
| Abbott | 69 | $20,364 |
| Altathera Pharmaceuticals LLC | 2 | $4,450 |
| Medical Device Business Services, Inc. | 7 | $2,858 |
| Atricure, Inc. | 2 | $151 |
| Ablacon, Inc. | 2 | $127 |
| Philips North America LLC | 1 | $125 |
| Varian Medical Systems, Inc. | 1 | $106 |
| Vital Connect, Inc | 1 | $102 |
| Cook Medical LLC | 1 | $101 |
| Pfizer | 4 | $63 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $42 |
| Impulse Dynamics (USA) Inc. | 1 | $26 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Cortex, Inc. | 1 | $19 |
| AstraZeneca | 1 | $15 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL EP$257,317
- GENERAL - THERAPIES$101,353
- Cardiva VASCADE MVP VVCS 6-12F$44,702
- Carto 3$40,234
- WATCHMAN Access System$29,907
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$14,566
- Watchman$11,250
- Cardiva VASCADE 5F VCS$8,685
- CARDIVA VASCADE MVP XL VVCS 10-12F$8,685
- Cardiva VASCADE 6/7F VCS$8,685
- Sotalol Hydrochloride$4,450
- ENSITE PRECISION$2,397
- WATCHMAN FLX$1,250
- ICEfx Cryoablation System$1,158
- Vascular Closure Device$1,000
- DiamondTemp$805
- EnSite Precision Cardiac Mapping System$649
- Arctic Front$600
- AVEIR$527
- AFFERA MAPPING SYSTEM$232
How this compares
$725,289 in reported general payments places this provider in the 95th percentile of 42 clinical cardiac electrophysiology providers in Alabama.
See all clinical cardiac electrophysiology providers in Alabama →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 71 | $68,698 |
| JardianceEmpagliflozin | 11 | $8,681 |
| Flecainide Acetate | 17 | $894 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 34 | $892 |
| SotalolSotalol Hcl | 29 | $677 |
| Amiodarone Hcl | 21 | $351 |
| Metoprolol Succinate | 13 | $125 |
| Carvedilol | 11 | $66 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $63 | $68,69871 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 42 clinical cardiac electrophysiology providers in Alabama.
Other clinical cardiac electrophysiology in Birmingham
- Anil RajendraBirmingham$495K
- Gustavo MoralesBirmingham$171K
- William MaddoxBirmingham$159K
- Francis BennBirmingham$95K
- Terence DunnBirmingham$73K
- Byron ColleyBirmingham$59K
- Macy SmithBirmingham$45K
- Chad ColonBirmingham$42K
- Blake SmithBirmingham$36K
- Ahmad JalladBirmingham$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.